Akebia Therapeutics AKBA
NASDAQ AKBA
$0.89 -0.01 (-0.78%)
At close: Sep 29, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) EV to EBIT (2025 - 2026)

Updated

Akebia Therapeutics' (AKBA) EV to EBIT came in at 39.65 for Q1 2026, up 284.3% from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) EV to EBIT (2025 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, EV to EBIT at Akebia Therapeutics was -52.72; for FY2025, it came in at 10.32.

  • Quarterly EV to EBIT has run from a low of 10.32 in Q4 2025 to a high of 1036.87 in Q2 2025 over five years.
  • According to Business Quant data, EV to EBIT for the three prior quarters was 10.32 (Q4 2025), 31.42 (Q3 2025) and 1036.87 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Akebia Therapeutics 241.85 Mn -427.63 Mn 38.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 39.65
Dec 31, 2025 10.32
Sep 30, 2025 31.42
Jun 30, 2025 1,036.87
API Access

Akebia Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AKBA&period=max&api_key=YOUR_API_KEY